Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. yueda@kuhp.kyoto-u.ac.jp.
Yoshihide
Y
Ueda
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shinji
S
Uemoto
D000328:Adult; D000368:Aged; D002219:Carbamates; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D007372:Interferons; D007546:Isoquinolines / Q000008:administration & dosage*; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000821:virology; D011759:Pyrrolidines; D012008:Recurrence; D012494:Sampling Studies; D013449:Sulfonamides / Q000008:administration & dosage*; D016559:Tacrolimus / Q000008:administration & dosage / Q000097:blood*; D014633:Valine / Q000031:analogs & derivatives
D002219:Carbamates; D007093:Imidazoles; D007546:Isoquinolines; D011759:Pyrrolidines; D013449:Sulfonamides; D007372:Interferons; D014633:Valine; C549273:daclatasvir; C571889:asunaprevir; D016559:Tacrolimus